411080 — Sands Lab Share Price
Last trade - 00:00- KR₩135bn
- KR₩101bn
- KR₩8bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.48 | ||
| Price to Tang. Book | 2.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 14.24 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.79% | ||
| Return on Equity | -5.21% | ||
| Operating Margin | -44.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 5,246.9 | 5,413.85 | 9,299.54 | 11,721.91 | 8,296.93 | n/a | n/a | 18.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +193.72 | -80.2 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sands Lab Inc is a Korea-based company mainly engaged in the cyber threat intelligence (CTI) business. The Company is engaged in the development of CTI platforms and response and prediction of cyber security threat based on the artificial intelligence and big data technology. The Company's products include malware network shield (MNX), malware document shield (MDX), malware agent shield (MAX) and other system integration (SI) platforms.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 1st, 2004
- Public Since
- February 15th, 2023
- No. of Shareholders
- 19,230
- No. of Employees
- 45
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 14,567,638
- Address
- 12F, 25, Gwacheon-daero 7na-gil, GWACHEON, 13840
- Web
- https://www.sandslab.io
- Phone
- +82 27047502
- Auditors
- Seowoo Accounting Corporation
Upcoming Events for 411080
Similar to 411080
Actoz Soft Co
Korea Exchange - KOSDAQ
Ahnlab
Korea Exchange - KOSDAQ
Alchera
Korea Exchange - KOSDAQ
Alticast
Korea Exchange - KOSDAQ
APS
Korea Exchange - KOSDAQ
FAQ
As of Today at 23:02 UTC, shares in Sands Lab are trading at KR₩8,110. This share price information is delayed by 15 minutes.
Shares in Sands Lab last closed at KR₩8,110 and the price had moved by -38.47% over the past 365 days. In terms of relative price strength the Sands Lab share price has underperformed the FTSE Developed Asia Pacific Index by -37.77% over the past year.
There is no consensus recommendation for this security.
Find out moreSands Lab does not currently pay a dividend.
Sands Lab does not currently pay a dividend.
Sands Lab does not currently pay a dividend.
To buy shares in Sands Lab you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩8,110, shares in Sands Lab had a market capitalisation of KR₩135bn.
Here are the trading details for Sands Lab:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 411080
Based on an overall assessment of its quality, value and momentum Sands Lab is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sands Lab. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +26.47%.
As of the last closing price of KR₩8,110, shares in Sands Lab were trading +2.71% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sands Lab PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩8,110.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Sands Lab's directors